Glucocerebrosidase gene therapy for Parkinson's disease Grant US-10967073-B2 United States of America 06 Apr 2021
GLUCOCEREBROSIDASE MUTANTS Application WO-2021048034-A1 World Intellectual Property Organisation (WIPO) 18 Mar 2021